Bausch + Lomb Corporation (BLCO)
NYSE: BLCO · IEX Real-Time Price · USD
14.24
-0.76 (-5.07%)
At close: Apr 12, 2024, 4:00 PM
14.28
+0.04 (0.28%)
After-hours: Apr 12, 2024, 7:58 PM EDT

Bausch + Lomb Revenue

In the year 2023, Bausch + Lomb had annual revenue of $4.15B with 10.03% growth. Revenue in the quarter ending December 31, 2023 was $1.17B with 17.77% year-over-year growth.

Revenue (ttm)
$4.15B
Revenue Growth
+10.03%
P/S Ratio
1.21
Revenue / Employee
$311,729
Employees
13,300
Market Cap
5.00B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20234.15B378.00M10.03%
Dec 31, 20223.77B3.00M0.08%
Dec 31, 20213.77B353.00M10.35%
Dec 31, 20203.41B-366.00M-9.69%
Dec 31, 20193.78B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Grifols 6.45B
Option Care Health 4.30B
R1 RCM 2.25B
Ionis Pharmaceuticals 787.65M
CRISPR Therapeutics AG 371.21M
Blueprint Medicines 249.38M
Krystal Biotech 50.70M
Revolution Medicines 11.58M
Revenue Rankings